2026 will bring more GLP-1 weight loss pills — and new habits. These stocks are poised to benefit
Novo Nordisk and Eli Lilly are expected to bring GLP-1 pills to market in the new year, which is expected to boost the number being treated.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
